Cipla agrees Rifaximin licensing deal

19-09-2014

Cipla agrees Rifaximin licensing deal

Christine Langer-Pueschel / Shutterstock.com

Indian drug maker Cipla has signed a deal with Salix Pharmaceuticals allowing the US-based company exclusive rights relating to the Rifaximin Complexes patent family.


Cipla, Rifaximin, Salix, patent

LSIPR